• Company
• NA bill to guarantee labor succession following M&A
• by May 28, 2021 06:08am

• Company
• Olumiant's indication for atopic dermatitis has expanded
• by May 28, 2021 06:08am

• InterView
• Leclaza's ASCO data is like a global champion
• by An, Kyung-Jin May 28, 2021 06:08am

• Policy
• One-time ￦2 billion therapy Zolgensma to be soon approved
• by Lee, Tak-Sun May 27, 2021 05:56am

• Company
• Daewoong & Dong-A succeeded in overcoming patent of Otezla
• by Kim, Jin-Gu May 27, 2021 05:56am

• Company
• AD drug ‘Dupixent’ records ￦13.5 bil. in Q1 with reimb.
• by An, Kyung-Jin May 27, 2021 05:56am

• Company
• Sales of EGFR anticancer drug Tagrisso have been put on hold
• by An, Kyung-Jin May 27, 2021 05:56am

• Policy
• Combination vaccine Priorix-tetra by GSK has been revoked
• by Lee, Tak-Sun May 27, 2021 05:55am

• Company
• MSD's HIV market entry to be discussed at June's DREC meetin
• by Eo, Yun-Ho May 26, 2021 06:06am

• Company
• Sales of obesity drugs have been on the decline
• by An, Kyung-Jin May 26, 2021 06:05am